IMIST


Pharmaceutical innovation, competition and patent law : (notice n° 51875)

000 -LEADER
fixed length control field 04190cam a2200457 i 4500
001 - CONTROL NUMBER
control field 17621743
003 - CONTROL NUMBER IDENTIFIER
control field IMIST
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20190828110512.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130211t20132013enk b 001 0 eng d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2013932949
015 ## - NATIONAL BIBLIOGRAPHY NUMBER
National bibliography number GBB359380
Source bnb
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 016448772
Source Uk
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780857932457 (hardback)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0857932454 (hardback)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9780857932464 (e-book)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 0857932462 (e-book)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)ocn852806743
040 ## - CATALOGING SOURCE
Original cataloging agency Uk
Language of cataloging eng
Transcribing agency Uk
Description conventions rda
Modifying agency OCLCO
-- YDXCP
-- IMIST
-- DGW-L
-- AzU
-- DLC
042 ## - AUTHENTICATION CODE
Authentication code lccopycat
043 ## - GEOGRAPHIC AREA CODE
Geographic area code n-us---
-- e------
-- a-ja---
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number K1519.D78
Item number P53 2013
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 346.0486
Edition number 23
245 00 - TITLE STATEMENT
Title Pharmaceutical innovation, competition and patent law :
Remainder of title a trilateral perspective /
Statement of responsibility, etc edited by Josef Drexl, Director, Max Planck Institute for Intellectual Property and Competition Law, Munich, Germanyl; Nari Lee, Professor of Intellectual Property Law, Department of Accounting and Commercial Law, Hanken School of Economics, Helsinki.
300 ## - PHYSICAL DESCRIPTION
Extent viii, 337 pages ;
Dimensions 25 cm
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 00 - FORMATTED CONTENTS NOTE
Title The patentability of genetic diagnostics in US law and policy /
Statement of responsibility Rochelle C. Dreyfuss --
Title Patentability of pharmaceutical innovations : the European perspective /
Statement of responsibility Rainer Moufang --
Title Patentability of medical methods in Japan /
Statement of responsibility Nari Lee --
Title Patent term restoration and non-patent exclusivity in the US /
Statement of responsibility Margo A. Bagley --
Title Clinical data, data exclusivity and private investment protection in Europe /
Statement of responsibility Christian R. Fackelmann --
Title Patent term extension in Japan : an academic and comparative perspective /
Statement of responsibility Ryoko Iseki --
Title Recent UK case law on supplementary protection certificates /
Statement of responsibility Richard Arnold --
Title Patent term extension in Japan : focusing on the Pacif Capsule decision /
Statement of responsibility Toshiaki Imura --
Title Strategic patenting by the pharmaceutical industry : towards a concept of abusive practices of protection /
Statement of responsibility Hanns Ullrich --
Title Anticompetitive marketing in the context of pharmaceutical switching in Europe /
Statement of responsibility Bengt Domeij --
Title AstraZeneca and the EU sector inquiry : when do patent filings violate competition law? /
Statement of responsibility Josef Drexl.
520 ## - SUMMARY, ETC.
Summary, etc Public health, safety and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals. Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination. The contributors to this book, including academics, judges and practitioners from Europe, the US and Japan, explore to what extent patent strategies and life-cycle management practices take advantage of patent laws and health-care regulation and disrupt the necessary balance between incentives for innovation and access to affordable medicine and health care. Addressing fundamental questions in the field of pharmaceutical innovation, this book will appeal to scholars and practitioners in intellectual property, competition law and life sciences regulation, as well as pharmaceutical companies and regulators.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
Geographic subdivision United States
General subdivision Patents.
9 (RLIN) 28360
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
Geographic subdivision European Union countries
General subdivision Patents.
9 (RLIN) 28361
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
Geographic subdivision Japan
General subdivision Patents.
9 (RLIN) 28362
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical industry
General subdivision Technological innovations.
9 (RLIN) 28363
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antitrust law
Geographic subdivision European Union countries.
9 (RLIN) 25645
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Drexl, Josef,
Relator term editor of compilation.
9 (RLIN) 28364
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lee, Nari,
Relator term editor of compilation.
9 (RLIN) 28365
856 41 - ELECTRONIC LOCATION AND ACCESS
Materials specified Table of contents only
Uniform Resource Identifier <a href="http://www.loc.gov/catdir/toc/fy14pdf04/2013932949.html">http://www.loc.gov/catdir/toc/fy14pdf04/2013932949.html</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Livre
Exemplaires
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Date acquired Inventory number Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          La bibliothèque des Sciences Juridiques, Economiques et de Gestion La bibliothèque des Sciences Juridiques, Economiques et de Gestion 08/28/2019 27700   346.0486 DRE 0000000030526 08/28/2019 08/28/2019 Livre
© Tous droits résérvés IMIST/CNRST
Angle Av. Allal Al Fassi et Av. des FAR, Hay Ryad, BP 8027, 10102 Rabat, Maroc
Tél:(+212) 05 37.56.98.00
CNRST / IMIST

Propulsé par Koha